Memorial Sloan Kettering Cancer Center: all 1,959 studies
Page 13 of 20. Open to participants first (325), then studies with results posted, then the rest; newest registration first within each.
- Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced PerfusionCompletedNCT02376127
- Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and CaregiversActive, not recruitingNCT02375841
- Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis SyndromesActive, not recruitingNCT02371135
- Testing a Personalize Medication Log for Patients With LymphomaCompletedNCT02370446
- Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer PatientsCompletedNCT02364726Not applicable
- Animal Assisted Activity Program on Patients and Staff on an Inpatient Surgical Oncology UnitCompletedNCT02363608
- 68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access TrialNo longer availableNCT02358018
- 18F-MFBG Imaging for Evaluation of Neuroendocrine MalignanciesCompletedNCT02348749Phase 1/2
- Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)CompletedNCT02315326Phase 1/2
- Evaluation of Treatment Response Using Multiparametric MRI After Prostate RadiotherapyActive, not recruitingNCT02312401Phase 2
- Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer ScreeningCompletedNCT02310698
- Study of Ibrutinib in Relapsed and Refractory T-cell LymphomaCompletedNCT02309580Phase 1
- PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot StudyActive, not recruitingNCT02307630Not applicable
- Yoga Practice for Breast or Ovarian Cancer PatientsCompletedNCT02305498Not applicable
- MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) StudyActive, not recruitingNCT02301767
- Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via VideoconferencingTerminatedNCT02301338
- [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate CancerCompletedNCT02297386Phase 1
- Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL InstrumentsCompletedNCT02296450
- Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial CancerActive, not recruitingNCT02285192Phase 1
- Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)CompletedNCT02282371Phase 1
- Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic RadiosurgeryActive, not recruitingNCT02278744Phase 1
- Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced CardiotoxicityCompletedNCT02274480
- Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial CancersCompletedNCT02269293Phase 1
- Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationActive, not recruitingNCT02269150Phase 2
- Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver BurdenCompletedNCT02250911Not applicable
- Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal IrradiationCompletedNCT02248779
- Local Control With Reduced-dose Radiotherapy for High-Risk NeuroblastomaCompletedNCT02245997Early Phase 1
- IFACT: Incidental Findings in Advanced Cancer TherapyCompletedNCT02217891
- Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative ManagementCompletedNCT02199236Phase 1
- Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell DiseaseCompletedNCT02193191Phase 1
- Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer PatientsCompletedNCT02186236
- Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid CancerCompletedNCT02178345
- Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast TomosynthesisCompletedNCT02174406
- Identifying and Measuring Depression in Older Cancer PatientsActive, not recruitingNCT02174055
- Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast CancerCompletedNCT02167854Phase 1
- A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the FemurActive, not recruitingNCT02164019Not applicable
- Development of Psychotherapeutic Interventions for Parents Who Lost a ChildActive, not recruitingNCT02153619Not applicable
- A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical CystectomyCompletedNCT02145871Phase 3
- Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot StudyCompletedNCT02145143Early Phase 1
- Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And GenomicsCompletedNCT02144311Not applicable
- Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to TherapyWithdrawnNCT02139150Not applicable
- Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell CarcinomaCompletedNCT02131805Not applicable
- Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking HistoryActive, not recruitingNCT02122107
- Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT02121990Phase 1
- Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung AdenocarcinomasCompletedNCT02120807Phase 1
- Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced CancerActive, not recruitingNCT02112188
- Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) SurvivorsCompletedNCT02106611
- Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal MetastasesActive, not recruitingNCT02106598Phase 1/2
- ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone AcetateCompletedNCT02106507Phase 1
- Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following HospitalizationCompletedNCT02099097Not applicable
- The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCCCompletedNCT02073903
- Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical RecurrenceCompletedNCT02070575
- Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerCompletedNCT02060253Phase 1
- 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain MetastasesCompletedNCT02037945Not applicable
- A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal CancerCompletedNCT02027948Not applicable
- Prognostic Awareness and Patient-Physician Communication in Malignant GliomaCompletedNCT02023346
- Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical ProstatectomyCompletedNCT02020070Phase 2
- Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementActive, not recruitingNCT02008656Phase 2
- Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After TestingCompletedNCT01992471
- MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)Active, not recruitingNCT01991379Phase 1/2
- A Registry for BRCA Mutation Carriers With Pancreatic Ductal AdenocarcinomaActive, not recruitingNCT01983410
- Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain MetastasisCompletedNCT01974804
- Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung CancerCompletedNCT01967095Phase 1
- Supervised Aerobic Training During or After Chemotherapy for Operable Breast CancerActive, not recruitingNCT01943695Not applicable
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic CholangiocarcinomaCompletedNCT01938729Phase 1
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaActive, not recruitingNCT01920737Phase 2
- PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-DerivativeCompletedNCT01916135Phase 1
- Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor StatusCompletedNCT01916122Early Phase 1
- Quit IT: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Following HospitalizationCompletedNCT01915836Not applicable
- Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology PatientsCompletedNCT01912131Not applicable
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin LymphomaCompletedNCT01908777Phase 2
- Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung CancerCompletedNCT01899989Phase 1
- Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic MeningiomaActive, not recruitingNCT01892397Not applicable
- Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life AssessmentActive, not recruitingNCT01888198
- Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close AlliesActive, not recruitingNCT01877070
- Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsActive, not recruitingNCT01873326Phase 2
- Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer MarginsCompletedNCT01872130
- Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaCompletedNCT01868451Not applicable
- Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing SarcomaActive, not recruitingNCT01864109Phase 2
- FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer PatientsCompletedNCT01864083Early Phase 1
- T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT01860937Phase 1
- Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on SorafenibActive, not recruitingNCT01840592Phase 2
- High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin LymphomaActive, not recruitingNCT01840566Phase 1
- Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive ChemoradiationWithdrawnNCT01836341Phase 1
- Breath Training Exercise for the Reduction of Chronic DyspneaCompletedNCT01831388Not applicable
- Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal CancerCompletedNCT01830582Not applicable
- Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their CaregiversCompletedNCT01829984
- Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase TherapyActive, not recruitingNCT01829958Not applicable
- ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal MetastasisActive, not recruitingNCT01815359Phase 2
- A Registry for Patients Treated on the Clinical Trial TAX 3503CompletedNCT01813370
- Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation PatientsCompletedNCT01811862Not applicable
- Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology SettingActive, not recruitingNCT01805609Not applicable
- Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino PopulationsTerminatedNCT01803750
- QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye LaserCompletedNCT01803516
- Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal CancerCompletedNCT01791309Phase 1
- Group Interventions for Breast Cancer SurvivorsActive, not recruitingNCT01775085Not applicable
- Clinical and Histopathologic Characteristics of BAP1 MutationsCompletedNCT01773655
- Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and MesotheliomaCompletedNCT01766739Phase 1
- Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01758328Phase 1
- Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk NeuroblastomaActive, not recruitingNCT01757626Phase 1/2
← Memorial Sloan Kettering Cancer Center overview and focus areas